SP
Insider
Sanj K Patel
CHAIRMAN & CEOSanj K Patel (CHAIRMAN & CEO) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Kiniksa Pharmaceuticals International, plc (KNSA). The largest single filing was $26.4M of KNSA (508,339 sh across 6 lots, as filed), executed Apr 28.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$39.4M
shares × price, as filed
Last traded
May 1
Filed May 1
Median ADV $60.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $44.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
KNSARecent filings
KNSASALE
Kiniksa Pharmaceuticals International, plc
View filing →
$2.6M48,565 sh × $54.02
Exec May 1
Filed May 1 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $26.4M
508,339 sh across 6 lots
Exec Apr 28
Filed Apr 30 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $364K
7,278 sh × $50.01
Exec Apr 6
Filed Apr 8 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $10.0M
257,969 sh across 4 lots
Exec Oct 20 2025
Filed Oct 22 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $2.3M
86,270 sh across 3 lots
Exec May 23 2025
Filed May 28 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $163K
6,029 sh × $27.05
Exec May 9 2025
Filed May 9 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $2.1M
89,561 sh × $23.00
Exec Nov 6 2024
Filed Nov 8 2024 · 5:30 PM ET